Abstract
The frequency of HLA class-I and class-II antigens was investigated in 32 Iranian patients with B-cell chronic lymphocytic leukemia (B-CLL), using the microlymphocytotoxicity method. A significant increase in the HLA- B13 (P<0.01) and DR53 (P < 0.05) and a significant negative association with the A11 (P < 0.05), B35 (P < 0.05), Cw3 (P < 0.05), and DR1 (P < 0.02) antigens were observed in these patients, compared to the control normal population. These results suggest involvement of some HLA antigens in the multif actorial process of predisposition to BCLL.
Similar content being viewed by others
References
Catovsky D, Foa R: The lymphoid leukemias. Buttenworth, London, 1990, pp. 73–111.
Cuttner J, Skerrett D, Rosina O, et al: Increased incidence of HLA antigen B35 in patients with chronic lymphocytic leukemia. Leukemia Res 18:565–567, 1994.
Dighiero G: Hypogammaglobulinemia and disordered immunity in CLL. In: Chronic lymphocytic leukemia, scientific advances and clinical developments. (Ed: Chosen BD). Marcel Dekker, New York, 1993, pp. 167–180.
Dorak MT, Chalmers EA, Gaffney D, et al: Human major histo-compatibility complex contains several leukemia susceptibility genes. Leuk Lymph 12:211–222, 1994.
Dorak MT, Owen G, Galbraith I, et al: Nature of HLA-associ-ated predispoisition to childhood acute lymphoblastic leukemia. Leukemia 9:875–878, 1995.
Dorak MT, Machulla HKJ, Hentschel M, et al: Influence of the major histocompatibility complex on age at the onest of chronic lymphocytic leukemia. Int J Cancer 65:134–139, 1996.
Dyer PA, Ridway JC, Flanagan NG: HLA-A, B and DR antigens in chronic lymphocytic leukemia. Dis Marker 4:231–237, 1986.
Gale RP, Foon KA, Arbor A: Chronic lymphocytic leukemia. Recent advances in biology and treatment. Ann Intern Med 103:101–120, 1985.
Gunz FM: The epidemiology and genetics of the chronic leukemias. Clin Hematol 69:3–20, 1977.
Jones HP, Whittaker JA: Chronic lymphocytic leukemia: an investigation of HLA antigen frequencies and white cell differential counts in patients, relatives and controls. Leuk Res 15:543–549, 1991.
Kilpatrick DC, Dewar AE, Stockdill G, et al: Histocompatibility antigen frequencies in patient with chronic lymphocytic leukemia: Possible identification of a subgroup with relatively benign disease. Scand J Haematol 33:391–396, 1984.
Khamesipur G, Mozdarani H. Shokri F: Cytogenetic analysis of malignant B-cells from Iranian patients with chronic lymphocytic leukemia. Irn J Med Sci 22:50–55, 1997.
Linet MS, Bias WB, Dorgan JF, et al: HLA antigens in chronic lymphocytic leukemia. Tissue Antigens 31:71–78, 1988.
Neuland CY, Blattner WA, Mann DL, et al: Familial chronic lymphocytic leukemia. J Natl Cancer Inst 71:1143–1150, 1983.
Nikbin B, khosravi F, Kamgouyan M et al: The dirstribution of class I and class II HLA antigens in Iranian population using 3rd. A.O.H.W.C. antisera. In: The proceeding of the 3rd Asia -Oceania histocompatability workshop conference. (Ed: Aizawa M), Hokkaido University Press, Sapporo, 1986, pp. 552–555.
Oomen LCJM, Van Der Valk MA, Hart AAM, et al: Influence of mouse major histocompatibility complex (H-2) on N-ethyl, N-nitrosourea induced tumor formation in various organs. Cancer Res 48:6634–6641, 1988.
Pawelec G, Rehbein A, Schaudt K, et al: Frequencies of HLA -DP allels in four major types of leukaemia. Tissue Antigens 34:138–140, 1989.
Raghoebier S, Van-Krieken JH, Kluin-Neleman JC, et al: On-cogene rearrangements in chronic B-cell leukemia. Blood77:1560–1565, 1991.
Rai KR, Sawitsky A, Cronkite EP, et al: Clinical staging of chronic lymphocytic leukemia. Blood 46:219–234, 1975.
Schroeder HW, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 15:288–294, 1994.
Seremetis S, Cuttner J, Winchester R: Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of polymorphic Ia epitope. J Clin Invest 76:1391–1397, 1985.
Shokri F, Mageed RA, Richardson P et al: Modulation and high frequency expression of autoantibody associated cross - reactive idiotypes linked to VH1 subgroup in CDS-expressing B-lymphocytes from patients with chronic lymphocytic leukemia (B-CLL). Stand J Immunol 37:673–679, 1993.
Sullivan KA, Amos DB: The HLA system and it’s detection. In: Manual of clinical laboratory immunology. (Eds: Rose NR, Friedman H, Fahey JL), 3rd ed., American Society for Micro-biolgy, Washington, 1986, pp. 835–846.
Svejgaard A: HLA and disease. In: Manual of clinical laboratory immunology. (Eds: Rose NR, Friedman H, Fahey JL), 3rd ed. American Society for Microbiology, Washington, 1986, pp. 912–920.
Terasaki PI, Bernoco D, Parks MS, et al: Microdroplet testing for HLA- A, B, C and DR antigens. Am J Clin Pathol 69:103–107, 1978.
Van Eijk MJT, Stewart-Hayens JA, Beever JE, et al: Development of persistent lymphocytosis in cattel is closely associated with DRB2. Immunogenetics 37:64–68, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moazzen, S.M., Amirzargar, A.A. & Shokri, F. HLA antigens in iranian patients with B-cell chronic lymphocytic leukemia. Pathol. Oncol. Res. 5, 142–145 (1999). https://doi.org/10.1053/paor.1999.0190
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1053/paor.1999.0190